Liu, Hui-Qi
Sun, Li-Xin
Yu, Long
Liu, Jun
Sun, Li-Chao
Yang, Zhi-Hua
Shu, Xiong
Ran, Yu-Liang
Funding for this research was provided by:
National Natural Science Foundation of China (82073278)
CAMS Innovation Fund for Medical Sciences (2021-I2M-1-067)
Beijing Natural Science Foundation (7222012)
Beijing Municipal Health Commission (BMHC-2021-6)
Article History
Received: 12 May 2022
Accepted: 16 August 2023
First Online: 27 September 2023
Declarations
:
: All animal procedures were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals, and the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. The protocol (Title “The research on the role and molecular basis of liver cancer metastasis stem cells in liver cancer metastasis and its antibody targeting therapy”) has been authorized by the institutional review board of Chinese Academy of Medical Sciences and Peking Union Medical College (Ethical Approval Number: NCC2017A014; Date, March 6, 2017) before the start of any protocol-specified procedures.
: Not applicable.
: The authors declare that they have no conflict of interest.